Pfizer To Provide Individual Participant Data At Scale
Source: Life Science Leader
By Aida Habtezion, MD, MSC, FRCPC, AGAF
The decision to join a clinical trial is personal. Each and every participant plays an important role in medical advancement. Historically, clinical trial sponsors have used participants’ data to learn more about the safety and efficacy of new treatments. But now, participants can have consistent and reliable access to their individual data. Pfizer has made a commitment to return individuals’ data to its clinical trial participants through its Participant Data Return initiative.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more